SAVIENT PHARMACEUTICALS, INC. AND U.S. BANK NATIONAL ASSOCIATION, as Trustee INDENTURE Dated as of February 4, 2011 4.75% Convertible Senior Notes due 2018Indenture • February 4th, 2011 • Savient Pharmaceuticals Inc • Medicinal chemicals & botanical products • New York
Contract Type FiledFebruary 4th, 2011 Company Industry JurisdictionINDENTURE dated as of February 4, 2011 between SAVIENT PHARMACEUTICALS, INC., a Delaware corporation, as issuer (the “Company”, as more fully set forth in Section 1.01) and U.S. BANK NATIONAL ASSOCIATION, a national banking association, as trustee (the “Trustee”, as more fully set forth in Section 1.01).